Australia markets closed

Immunovant, Inc. (IMVT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
28.74+0.52 (+1.84%)
At close: 04:00PM EDT
29.24 +0.50 (+1.74%)
Pre-market: 04:33AM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1481414
Avg. Estimate-0.43-0.45-1.77-1.87
Low estimate-0.49-0.53-1.93-2.27
High estimate-0.35-0.39-1.4-0.83
Year ago EPS-0.46-0.57-1.71-1.77
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts851111
Avg. EstimateN/AN/AN/A16.42M
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/A180.6M
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.43-0.45-0.47-0.43
Actual EPS-0.46-0.57-0.45-0.36
Difference-0.03-0.120.020.07
Surprise %-7.00%-26.70%4.30%16.30%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.43-0.45-1.77-1.87
7 days ago-0.43-0.45-1.79-1.88
30 days ago-0.43-0.45-1.79-1.87
60 days ago-0.43-0.47-1.8-1.86
90 days ago-0.45-0.51-1.89-1.93
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 days1N/A1N/A
Up last 30 days2121
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesIMVTIndustrySector(s)S&P 500
Current qtr.6.50%N/AN/AN/A
Next qtr.21.10%N/AN/AN/A
Current year-3.50%N/AN/AN/A
Next year-5.60%N/AN/AN/A
Next 5 years (per annum)3.69%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A